Aptus Capital Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-691
| Closed | -$46K | – | 800 |
|
|
2022
Q3 | $46K | Buy |
691
+10
| +1% | +$666 | ﹤0.01% | 555 |
|
|
2022
Q2 | $28K | Sell |
681
-152
| -18% | -$6.25K | ﹤0.01% | 508 |
|
|
2022
Q1 | $42K | Hold |
833
| – | – | ﹤0.01% | 512 |
|
|
2021
Q4 | $50K | Sell |
833
-234
| -22% | -$14K | ﹤0.01% | 418 |
|
|
2021
Q3 | $53K | Sell |
1,067
-156
| -13% | -$7.75K | ﹤0.01% | 389 |
|
|
2021
Q2 | $70K | Buy |
1,223
+153
| +14% | +$8.76K | ﹤0.01% | 393 |
|
|
2021
Q1 | $61K | Sell |
1,070
-1,207
| -53% | -$68.8K | ﹤0.01% | 371 |
|
|
2020
Q4 | $154K | Buy |
+2,277
| New | +$154K | 0.01% | 297 |
|